A new study has found that marijuana products dominant in CBD can ease anxiety more effectively in comparison to products that contain THC. THC and CBD are the two primary compounds found in marijuana. However, unlike CBD, THC induces a high when ingested.
The study was carried out by researchers at CU Boulder. It is the first randomized trial to investigate how commercially available marijuana influences symptoms of anxiety.
Currently, one in five adults in America have an anxiety disorder, which makes it a common mental health condition in the United States. The researchers’ primary objective was to better understand the short- and long-term effects of THC and CBD on anxiety symptoms. The researchers recruited 300 individuals who suffered from anxiety. More than 250 of the participants had previously tried marijuana while the rest hadn’t.
Those who had tried the drug before were required to use a product that was CBD dominant, one that was THC dominant or a product that had equal parts CBD and THC. During a four-week period, the participants were allowed to use the products as much as they desired. During this same period, the researchers tested every participant before and immediately after they had smoked marijuana.
The researchers determined that while all participants reported reductions in their anxiety, those who used the marijuana products reported a greater decrease in perceived anxiety in comparison to those who hadn’t used marijuana before.
Additionally, the participants who used the products that had more CBD recorded the biggest improvements in their anxiety symptoms. Participants in this group were also less likely to experience paranoia after using the drug in comparison to the other two groups. This is in addition to feeling less tense after they had indulged.
Associate professor L. Cinnamon Bidwell, the study’s senior author, stated that CBD was linked to anxiety and tension relief with limited harm in the short-term. She explained that CBD had more anti-inflammatory properties than THC, which could mean that CBD-heavy products could decrease anxiety by soothing inflammation in nerves and in the brain. Bidwell noted that despite these findings, more data was needed to definitively state that there were long-term beneficial effects of CBD for anxiety.
It is important to note that federal law prohibits the distribution or possession of commercially available marijuana on college campuses, including for research purposes. Participants involved in this study were directed to buy their designated product from a chosen dispensary and use it off campus, on their own time.
The researchers reported their findings in the “Cannabis and Cannabinoid Research” journal.
Such studies are likely to encourage more patients to try medical marijuana products from licensed companies such as Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) for conditions, such as anxiety, which they struggle with and seek for alternatives to conventional medications.
About CannabisNewsWire
CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN
